Pfizer seeks FDA approval for a Third “Booster” shot to specifically target the Delta Variant
Pfizer hopes to obtain U.S. approval for a third booster shot as the delta variant of the COVID-19 virus continues to spread worldwide, according to Reuters. Mikael Dolsten, the company’s Chief Scientific Officer, said the vaccine’s effectiveness tends to decline after six months as antibodies begin to wane. Hence, Pfizer suggests administering a third shot since a recent study showed promising signs against the virus with a five-to-ten-fold increase in […]
